The name itself, SMGT-GLP-1, is designed to make you think you are getting actual GLP-1 technology
This primarily appears to be due to clinical results since GLP-1s lower A1C, reduce weight, improve cardiovascular outcomes, and potentially many other benefits
Repeated acid exposure can lead to permanent damage if not addressed early
Another patient may tolerate topiramate at a modest dose but require gradual increases in phentermine over several weeks
25, 2025 (HealthDay News) Women who stop taking a GLP-1 weight loss/diabetes medication just prior to a pregnancy appear to be at higher odds for excess weight gain and complications while pregnant, new research shows
Retatrutides Phase 2 trial data showed 24.2% average weight loss at the 12 mg dose over 48 weeks